These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32152070)

  • 1. Efficient CRISPR/Cas9 Gene Editing in Uncultured Naive Mouse T Cells for In Vivo Studies.
    Nüssing S; House IG; Kearney CJ; Chen AXY; Vervoort SJ; Beavis PA; Oliaro J; Johnstone RW; Trapani JA; Parish IA
    J Immunol; 2020 Apr; 204(8):2308-2315. PubMed ID: 32152070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid and Efficient Gene Editing for Direct Transplantation of Naive Murine Cas9
    Majumder S; Jugovic I; Saul D; Bell L; Hundhausen N; Seal R; Beilhack A; Rosenwald A; Mougiakakos D; Berberich-Siebelt F
    Front Immunol; 2021; 12():683631. PubMed ID: 34367143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid and efficient generation of antigen-specific isogenic T cells from cryopreserved blood samples.
    Eerkens AL; Vledder A; van Rooij N; Foijer F; Nijman HW; de Bruyn M
    Immunol Cell Biol; 2022 Apr; 100(4):285-295. PubMed ID: 35194830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of microsatellite instability in CRISPR/Cas9 editing mice.
    Huo X; Du Y; Lu J; Guo M; Li Z; Zhang S; Li X; Chen Z; Du X
    Mutat Res; 2017 Mar; 797-799():1-6. PubMed ID: 28284774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient Genome Engineering of a Virulent Klebsiella Bacteriophage Using CRISPR-Cas9.
    Shen J; Zhou J; Chen GQ; Xiu ZL
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29899105
    [No Abstract]   [Full Text] [Related]  

  • 6. Naïve Primary Mouse CD8
    Pfenninger P; Yerly L; Abe J
    Front Immunol; 2022; 13():777113. PubMed ID: 35844563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical cancer vulnerabilities identified by unbiased CRISPR/Cas9 screens inform on efficient cancer Immunotherapy.
    Potts MA; McDonald JA; Sutherland KD; Herold MJ
    Eur J Immunol; 2020 Dec; 50(12):1871-1884. PubMed ID: 33202035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome editing of rodents by electroporation of CRISPR/Cas9 into frozen-warmed pronuclear-stage embryos.
    Kaneko T; Nakagawa Y
    Cryobiology; 2020 Feb; 92():231-234. PubMed ID: 31987837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and application of CRISPR/Cas9 technologies in genomic editing.
    Zhang C; Quan R; Wang J
    Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR-Cas9 for cancer therapy: Opportunities and challenges.
    Chen M; Mao A; Xu M; Weng Q; Mao J; Ji J
    Cancer Lett; 2019 Apr; 447():48-55. PubMed ID: 30684591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent developments in enhancing the efficiency of CRISPR/Cas9- mediated knock-in in animals].
    Li GL; Yang SX; Wu ZF; Zhang XW
    Yi Chuan; 2020 Jul; 42(7):641-656. PubMed ID: 32694104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient genome editing of Brassica campestris based on the CRISPR/Cas9 system.
    Xiong X; Liu W; Jiang J; Xu L; Huang L; Cao J
    Mol Genet Genomics; 2019 Oct; 294(5):1251-1261. PubMed ID: 31129735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of novel Il2rg-knockout mice with clustered regularly interspaced short palindromic repeats (CRISPR) and Cas9.
    Byambaa S; Uosaki H; Hara H; Nagao Y; Abe T; Shibata H; Nureki O; Ohmori T; Hanazono Y
    Exp Anim; 2020 Apr; 69(2):189-198. PubMed ID: 31801915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
    Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
    J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of CRISPR/Cas9 gene-editing tools for developing models in drug discovery.
    Ahmad G; Amiji M
    Drug Discov Today; 2018 Mar; 23(3):519-533. PubMed ID: 29326075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in therapeutic CRISPR/Cas9 genome editing.
    Savić N; Schwank G
    Transl Res; 2016 Feb; 168():15-21. PubMed ID: 26470680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Toolkit of CRISPR-Based Genome Editing Systems in Drosophila.
    Xu J; Ren X; Sun J; Wang X; Qiao HH; Xu BW; Liu LP; Ni JQ
    J Genet Genomics; 2015 Apr; 42(4):141-9. PubMed ID: 25953352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR-Directed Gene Editing Catalyzes Precise Gene Segment Replacement
    Sansbury BM; Wagner AM; Tarcic G; Barth S; Nitzan E; Goldfus R; Vidne M; Kmiec EB
    CRISPR J; 2019 Apr; 2():121-132. PubMed ID: 30998096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
    Doetschman T; Georgieva T
    Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmid- or Ribonucleoprotein-Mediated CRISPR/Cas Gene Editing in Primary Murine T Cells.
    Dölz M; Marone R; Jeker LT
    Methods Mol Biol; 2021; 2285():255-264. PubMed ID: 33928558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.